• 1-240-425-7688
  • info@bla-regulatory.com
logo
  • Services
    • Biopharmaceutical Consulting
      • Gap Analysis
      • Health Authority Meetings
      • IND Filing & Maintenance
      • Leading PI Recruitment
      • U.S. Agent Representation
      • Clinical Trials Registration
      • Strategy Development
      • Medical Writing
      • BLA, NDA Filing & Maintenance
      • Global Regulatory Reach
      • eCTD Publishing & Submission
      • Expedited Regulatory Programs
    • Medical Device Consulting
      • Medical Device Applications
      • Medical Device Reimbursement Services
    • Business Development Consulting
  • Consultants
  • About Us
    • About Us
    • FAQ
    • Career
  • Insights
    • Regulatory Intelligence
      • Weekly PharmaFocus
      • Monthly MedTech Orbit
      • Quarterly PharmaSphere
    • News
    • Events
    • Webinars
  • Contact

Home
no image found
Healthcare professional monitoring a clinical trial participant during an investigator-initiated study in a healthcare setting

Unlocking the Value of Investigator-Initiated Trials Across US, EU, Japan & China

...
Yuka Osada No Comments
no image found
Digital CRISPR gene editing technology showing DNA strands and genome modification for advanced cell and gene therapy development.

Prior Knowledge Advantage for GE Products: From US IND to BLA

...
Yuka Osada No Comments
no image found
Adverse event reporting concept showing FDA safety monitoring icons, pharmacovigilance signals, and medical data analytics dashboard

US FDA’s New AEMS Platform: One Dashboard, Millions of Safety Signals

...
Yuka Osada No Comments
no image found
Scientist using pipette and microscope to analyze biologic samples for biosimilar analytical similarity testing

Can Your Biosimilar Skip Phase 3 Trials? US FDA’s Biosimilar Rules Explained

...
Yuka Osada No Comments
no image found
Biotech startup team discussing clinical and scientific data for drug development strategy

From Foreign Phase 1 Studies to U.S. Phase 2: Getting EOP1 Meetings Right

...
Yuka Osada No Comments
no image found

Latest News: Proposed US-FDA Scrutiny on Cross-Border Clinical Data!

...
Yuka Osada No Comments
no image found

U.S. FDA Tightens Oversight of Cross-border Cell Exports!

...
Yuka Osada No Comments
no image found

Japan Clinical Trials Unlocked: PMDA Pre-Consultation to First Patient In

...
Yuka Osada No Comments
no image found
Comparison of FDA Fast Track vs. Breakthrough Therapy pathways with clinical and regulatory strategy focus

Fast Track vs. Breakthrough Therapy: Key Clinical Strategy Differences

...
Yuka Osada No Comments
no image found
High-resolution Layer 7-T Cortical Interface device by Precision Neuroscience, FDA-cleared for hospital-ready brain–computer interface applications.

Precision Neuroscience Secures FDA Approval: Layer 7-T Device Redefines Clinical-Ready Brain–Computer Interfaces

...
Yuka Osada No Comments
1 2 Next Page »

Join Our Newsletter
  Thank you for Signing Up
Please correct the marked field(s) below.
1,true,6,Contact Email,21,false,1,First Name,21,false,1,Last Name,2

 

9841 Washingtonian Blvd, Suite 200
Gaithersburg, MD 20878, USA

1-240-425-7668
info@bla-regulatory.com

© 2026 BLA Regulatory. All Rights Reserved.

Privacy Policy | Terms & Conditions

Website designed and maintained by USABAL Solutions